Free Trial
NASDAQ:TLIS

Talis Biomedical (TLIS) Stock Price, News & Analysis

Talis Biomedical logo
$1.72
0.00 (0.00%)
(As of 11/1/2024 ET)

About Talis Biomedical Stock (NASDAQ:TLIS)

Key Stats

Today's Range
$1.72
$1.72
50-Day Range
$1.37
$4.38
52-Week Range
$1.37
$9.60
Volume
32 shs
Average Volume
4,755 shs
Market Capitalization
$3.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

Receive TLIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Talis Biomedical and its competitors with MarketBeat's FREE daily newsletter.

TLIS Stock News Headlines

True paradigm shift
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Talis Biomedical Corp Ordinary Shares
See More Headlines

TLIS Stock Analysis - Frequently Asked Questions

Talis Biomedical's stock was trading at $7.45 at the beginning of the year. Since then, TLIS stock has decreased by 76.9% and is now trading at $1.72.
View the best growth stocks for 2024 here
.

Talis Biomedical Co. (NASDAQ:TLIS) issued its quarterly earnings results on Monday, August, 19th. The company reported ($4.86) earnings per share (EPS) for the quarter. Talis Biomedical had a negative trailing twelve-month return on equity of 79.74% and a negative net margin of 5,784.73%.

Shares of Talis Biomedical reverse split on the morning of Thursday, July 6th 2023. The 1-15 reverse split was announced on Thursday, July 6th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, July 6th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Talis Biomedical (TLIS) raised $150 million in an initial public offering on Friday, February 12th 2021. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan, BofA Securities and Piper Sandler served as the underwriters for the IPO and BTIG was co-manager.

Shares of TLIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Talis Biomedical investors own include Bloom Energy (BE), SoFi Technologies (SOFI), Athenex (ATNX), Alkaline Water (WTER), Milestone Scientific (MLSS), TherapeuticsMD (TXMD) and Affirm (AFRM).

Company Calendar

Last Earnings
8/19/2024
Today
11/02/2024
Next Earnings (Estimated)
11/12/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Analytical instruments
Sub-Industry
Measuring And Control Equipment
Current Symbol
NASDAQ:TLIS
Fax
N/A
Employees
260
Year Founded
N/A

Profitability

Net Income
$-62,010,000.00
Net Margins
-5,784.73%
Pretax Margin
-12,506.37%

Debt

Sales & Book Value

Annual Sales
$2.13 million
Book Value
$37.95 per share

Miscellaneous

Free Float
984,000
Market Cap
$3.13 million
Optionable
No Data
Beta
1.56
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:TLIS) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners